Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
GTXI: Stock Quote & Summary Data
7.34%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 865,259 |
| Previous Close | $ 3.27 |
| 52 Wk High / Low | $ 18.75 / $ 3.22 |
| Shares Outstanding | 36,418,000 |
| Market Value | $ 127,827,180 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.5 |
| NASDAQ Official Open Price: | $ 3.32 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 3.51 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About GTXI?
Ask your question about about GTx, Inc. (GTXI) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
GTx, Inc., a Delaware corporation incorporated on September 24, 1997, is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other serious medical conditions. We are developing ACAPODENE® (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: first, a pivotal Phase III clinical trial for the treatment of multiple serious side effects of androgen deprivation therapy, or ADT, for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with precancerous prostate lesions called high grade prostatic intraepithelial neoplasia, or high grade PIN. ... More ...
Links to all GTx, Inc. (GTXI) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for GTXI |
||
|
GTx Announces Corporate Presentation at Lazard Capital Markets Annual Healthcare Conference - Business Wire 11/11/2009 7:00AM |
||
|
GTX Q3 Loss Widens - Update - RTT News 11/09/2009 12:28PM |
||
|
GTx Q3 Loss Widens; Meets Consensus - Quick Facts - RTT News 11/09/2009 7:26AM |
||
|
GTX Q3 09 Earnings Conference Call At 9:00 AM ET - RTT News 11/09/2009 7:14AM |
||
|
GTx, Inc. Reports Third Quarter 2009 Corporate Results - Business Wire 11/09/2009 7:00AM |
||
|
Stocks Set To Extend Gains - RTT News 11/09/2009 6:35AM |
||
|
Retailers To Hog Spotlight On Earnings Front - RTT News 11/09/2009 2:54AM |
